MedMira (MedMira) Price-to-Operating-Cash-Flow : (As of May. 16, 2024)

View and export this data going back to . Start your Free Trial

What is MedMira Price-to-Operating-Cash-Flow?

As of today (2024-05-16), MedMira's share price is $0.06. MedMira's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.00. Hence, MedMira's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for MedMira's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, MedMira's highest Price-to-Operating-Cash-Flow Ratio was 20.00. The lowest was 0.00. And the median was 20.00.

MMIRF's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.61
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

MedMira's Cash Flow from Operations per share for the three months ended in Jan. 2024 was $-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.00.

During the past 13 years, MedMira's highest 3-Year average Operating Cash Flow per Share Growth Rate was 52.10% per year. The lowest was -44.20% per year. And the median was 29.10% per year.

MedMira Price-to-Operating-Cash-Flow Historical Data

The historical data trend for MedMira's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Price-to-Operating-Cash-Flow Chart

MedMira Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

MedMira Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of MedMira's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, MedMira's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMira's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where MedMira's Price-to-Operating-Cash-Flow falls into.

MedMira Price-to-Operating-Cash-Flow Calculation

MedMira's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.06	/	-0.003
	=

MedMira's Share Price of today is $0.06.
MedMira's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

MedMira Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of MedMira's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira (MedMira) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

47M:Germany MIR:Canada

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.